This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Guillaume Jacquot, Ph.D
Translational Research Manager at Vect-Horus
Speaker

Profile

Dr. Guillaume JACQUOT has 15 years of experience in scientific project management in various fields, including cellular biology, virology, cardiovascular, neurobiology and cancer. His expertise extends from early R&D to regulatory preclinical and early clinical development. He joined VECT-HORUS in 2010 where he is Responsible for the translation of early discoveries into internal added-value and collaborative projects. He has also created and manages a platform dedicated to the analysis of the intracellular pharmacokinetics (ICPK) profile of targeted drug candidates.

Agenda Sessions

  • TfR-targeting VHH Nanobodies for Extra-hepatic Delivery of Oligonucleotides

    On Demand - Premium Only
    View Session

At this event

Prev
Next
Maja Janas De Angelis, PhD, DABT
Associate Director, Investigative Toxicology
Alnylam Pharmaceuticals

See Guillaume at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub